Endo Health Solutions Inc., now has a new chief executive officer to go along with a new headquarters in Malvern, as the board of directors announced Monday that Rajiv De Silva will lead the drug and device company.
Investors hope the stock price, revenue, and profits will also take a new direction - higher, of course - when the former Novartis and Valeant Pharmaceuticals executive takes over on March 18. Dave Holveck announced late last year that he would retire.
De Silva, 46, will make $975,000 in salary and more through incentives and stock options, but he did not land this job because he mixed molecules in a lab. He earned degrees in civil engineering at Princeton and Stanford before getting his MBA at Wharton. After time at McKinsey & Co., he worked for Novartis and then Valeant Pharmaceuticals, where he was involved in the acquisition and integration of 40 companies.